<level type="section">
  <num>28-4553</num>
  <heading>Excessive pricing in sales of prescription drugs, a violation of law.</heading>
  <text>It shall be unlawful for any drug manufacturer or licensee thereof, excluding a point of sale retail seller, to sell or supply for sale or impose minimum resale requirements for a patented prescription drug that results in the prescription drug being sold in the District for an excessive price.</text>
  <level type="annotations">
    <level>
      <heading>History</heading>
      <text>(Dec. 10, 2005, D.C. Law 16-37, ยง 2, 52 DCR 9061.)</text>
    </level>
    <level>
      <heading>Legislative History of Law 16-37</heading>
      <text>For Law 16-37, see notes following ยง 28-4551.</text>
    </level>
  </level>
</level>
